Clinical trial

Study of GTx-024 on Muscle Wasting (Cachexia) Cancer.

NCT00467844

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2007-05-01

PhasePHASE2

Study timeline

Study start (unknown)2007-05-01Date precision: month

Registry last updated2014-07-11

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Cachexiaunresolved

Interventions

GTx-024DRUG

PlaceboDRUG

Sponsors & collaborators

GTxlead sponsor

Mapped research locations

MemphisTennessee, United States2 Fountain ValleyCalifornia, United States2 DallasTexas, United States1 BaltimoreMaryland, United States1 MiamiFlorida, United States1 TorontoOntario, Canada1 OmahaNebraska, United States1 CharlestonSouth Carolina, United States1 BethesdaMaryland, United States1 LouisvilleKentucky, United States1 Kansas CityMissouri, United States1 EdmontonAlberta, Canada1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00467844 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.